Autolus Therapeutics (AUTL) Shares Outstanding (2017 - 2025)

Autolus Therapeutics (AUTL) has reported Shares Outstanding (Entity) for 9 consecutive years, with $266.1 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $266.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $266.1 million (changed 0.0% YoY) and the FY2025 annual result came in at $266.1 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) steadied at $266.1 million in Q4 2025 per AUTL's latest filing, from $266.1 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for AUTL reached as high as $266.1 million in Q3 2025 and fell as low as $62.4 million in Q1 2021.
• A 5-year average of $173.5 million and a median of $173.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 91.05% — and 2025, when it gained 0.0%.
• Year by year, Shares Outstanding (Entity) stood at $72.1 million in 2021, then soared by 31.78% to $95.0 million in 2022, then soared by 83.28% to $174.1 million in 2023, then surged by 52.86% to $266.1 million in 2024, then rose by 0.0% to $266.1 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $266.1 million, $266.1 million, and $266.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.